Alexandra Global Master Fund

Alexandra Global Master Fund is a prominent investment vehicle managed by Alexandra Investment Management, a New York-based hedge fund founded in 1999. The fund primarily employs convertible arbitrage and event-driven investment strategies, with a significant portion of its portfolio dedicated to the healthcare and biotechnology sectors. It frequently provides capital to small- and mid-cap life sciences companies through private investments in public equity (PIPEs) and convertible debt offerings. By acting as a strategic financier, the fund supports the development of various therapeutic programs across the biotech industry without directly engaging in internal research and development. Its activities are often documented in regulatory filings for developmental-stage pharmaceutical firms seeking to fund clinical trials.